The aim of this review is to show that the understanding of the connection of specific Aβ and tau pathology in AD with mitochondrial dysfunction and oxidative stress, together with the consideration of the function of CoQ10, give the potential for further research into the role of CoQ10 and its analogues in the treatment of AD. The gene discussed is MAPT; the disease is Alzheimer disease.